Atlas Trials

Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)

Clinical trial NCT00612859 · COMPLETED

Trial details

NCT number
NCT00612859
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anxiety Disorders
Start date
2003-09-01
Primary completion
2004-06-01
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.